endpts.com rank 334 |
Number of domains linking to endpts.com 2 | semantic flow 0.2 |
Number of links to endpts.com 3 | semantic flow 0.2 |
Number of domains linked from endpts.com 4 | semantic flow 0.38 |
Number of links from endpts.com 4 | semantic flow 0.38 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
https://endpts.com/in-a-pioneering-first-astrazeneca-scores-fda-ok-to-use-its-parp-against headed for a blockbuster smash roche picks up another key ok for landmark ms drug ocrevus ↳https://endpts.com/headed-for-a-blockbuster-smash-roche-picks-up-another-key-ok-for-landma | |
https://endpts.com/the-gene-therapy-pricing-debate-gets-real-as-spark-sets-850000-charge-f bluebird hopes for 3 drug approvals by 2019 including car t and gene therapies ↳https://endpts.com/bluebird-will-ask-for-3-drug-approvals-by-2019-including-car-t-and-gene |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Headed for a blockbuster smash, Roche picks up another key OK for landmark MS drug Ocrevus u2013 Endpoints News https://endpts.com/headed-for-a-blockbuster-smash-roche-picks-up-another-key-ok-for-landma | 0.28 | 1 | 25 | 7 | 1 | 1 | 0 | 0 | |
The gene therapy pricing debate gets real as Spark sets $850,000 charge for its pioneering drug u2013 Endpoints News https://endpts.com/the-gene-therapy-pricing-debate-gets-real-as-spark-sets-850000-charge-f | 0.19 | 0.82 | 24 | 5 | 0 | 0 | 0 | 0 | |
In a pioneering first, AstraZeneca scores FDA OK to use its PARP against breast cancer u2013 Endpoints News https://endpts.com/in-a-pioneering-first-astrazeneca-scores-fda-ok-to-use-its-parp-against | 0.19 | 1 | 24 | 7 | 1 | 1 | 0 | 0 | |
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma u2013 Endpoints News https://endpts.com/drugmakers-take-to-japan-3-new-drug-approvals-won-by-astrazeneca-merck- | 0.19 | 1 | 25 | 7 | 1 | 1 | 0 | 0 | |
Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field u2013 Endpoints News https://endpts.com/little-alder-bags-positive-phiii-migraine-data-but-giant-rivals-are-rac | 0.19 | 0.96 | 23 | 3 | 0 | 0 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://coreynahman.com/ | 2 | 0.13 | coreynahman.com |
http://cbsnews.com/ | 1 | 0.07 | cbsnews.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://roche.com/ | 1 | 0.14 | roche.com |
http://merck.com/ | 1 | 0.09 | merck.com |
http://alderbio.com/ | 1 | 0.08 | alderbio.com |
http://marktpuls.ch/ | 1 | 0.07 | marktpuls.ch |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://endpts.com/category/pricing/ | 1 | 0.19 | 0.98 | 0.09 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://endpts.com/the-gene-therapy-pricing-debate-gets-real-as-spark-sets-850000-charge-f | 1 | 0.19 | 0.98 | 0.09 | 0.82 | yes | 24 | 5 | 0 | 0 | 0 | 0 | |
https://endpts.com/tired-of-being-gouged-for-old-cheap-therapies-a-consortium-of-hospitals | 1 | 0.19 | 0.98 | 0.09 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://endpts.com/new-drug-price-controversy-looms-as-biogen-stuns-payers-with-spinrazas- | 1 | 0.18 | 0.92 | 0.07 | 1 | yes | 23 | 6 | 0 | 0 | 1 | 1 | |
https://endpts.com/novartis-scores-a-quick-fda-ok-for-its-new-cancer-drug-lutathera-picked | 1 | 0.18 | 0.98 | 0.07 | 0.99 | yes | 23 | 5 | 0 | 0 | 0 | 0 | |
https://endpts.com/category/drug-development/ | 1 | 0.18 | 0.98 | 0.07 | 1 | yes | 38 | 9 | 0 | 0 | 0 | 0 | |
https://endpts.com/senator-harris-comes-out-swinging-against-alkermes-and-its-ceo-criticiz | 1 | 0.18 | 0.89 | 0.07 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://endpts.com/news/ | 1 | 0.18 | 0.91 | 0.07 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://endpts.com/fda-slaps-down-braeburn-on-opioid-addiction-drug-putting-indivior-and-a | 1 | 0.15 | 0.98 | 0.07 | 1 | yes | 25 | 5 | 0 | 0 | 1 | 1 | |
https://endpts.com/roche-scores-an-unusual-breakthrough-at-the-fda-for-an-autism-drug/ | 1 | 0.15 | 0.98 | 0.06 | 1 | yes | 24 | 4 | 1 | 1 | 1 | 1 |
Pages from domain with most likely on-topic outgoing links.
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.